Koortslipcrème Aciclovir Jumbo

Aciclovir, the active ingredient in Koortslipcrème Aciclovir Jumbo, is an antiviral presented as a cream for topical use. It treats herpes labialis (cold sores) in adults and children.

GNH USA supplies Koortslipcrème Aciclovir Jumbo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Aciclovir acts on the herpes simplex virus family to limit replication and accelerate lesion healing. - Herpes labialis: topical treatment that shortens lesion duration and reduces pain. - Cold sores: antiviral therapy that limits viral spread and speeds recovery. - Recurrent lip herpes infections: helps control outbreak frequency and severity.

Aciclovir cream is generally well tolerated, but local reactions may occur.

Common Side Effects: - Mild skin irritation: redness or discomfort at the application site. - Burning sensation: transient warmth after application. - Itching: mild pruritus localized to treated area. - Dryness: temporary loss of moisture on the skin. - Redness: slight erythema around lesions. - Peeling: superficial desquamation after use.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or severe rash. - Contact dermatitis: intense inflammation of the skin. - Severe skin rash: blistering or necrotic lesions. - Swelling of lips or face: signs of systemic hypersensitivity. - Anaphylaxis (rare): rapid onset of breathing difficulty and hypotension.

Use Koortslipcrème Aciclovir Jumbo only as directed and observe the following safety measures. - Apply to affected area only: avoid eyes, mouth and mucous membranes. - Do not use on extensive skin damage: limit to small, isolated lesions. - Avoid use in patients with known hypersensitivity to aciclovir or related compounds. - Consult a healthcare professional if pregnant or breastfeeding: safety data are limited. - Store at room temperature: keep in the original packaging, protect from moisture and heat.

Topical aciclovir has limited systemic absorption, yet certain co‑applications may affect safety or efficacy.

Major Interactions (Avoid): - Concurrent use of other topical antiviral preparations: may increase local irritation. - Simultaneous systemic aciclovir therapy: monitor for cumulative toxicity.

Moderate Interactions (Monitor Closely): - Use with corticosteroid creams: may mask irritation signs. - Application with skin irritants (e.g., harsh soaps): monitor for increased sensitivity. - Use with sunscreen: apply sunscreen after the cream has fully dried to avoid dilution.